Global 3D Bioprinting market will reach $6,760.5 million by 2031, growing by 19.7% annually over 2021-2031, driven by the increasing prevalence of chronic respiratory and cardiovascular disorders (CVDs) due to the aging population, the rising requirement for regenerative medicines/cancer therapeutics/stem cell solutions, the rising governments and private funding, and the technological advancements such as the development of AI and organ-on-a-chip.
Highlighted with 88 tables and 88 figures, this 186-page report "Global 3D Bioprinting Market 2021-2031 by Component (Bioprinters, Bioinks), Material (Living Cells, Hydrogels, Extracellular Matrices), Technology (Inkjet, Laser-assisted, Magnetic, Microextrusion), Application (Research, Clinical), End User (Research Organization, Biopharma Companies, Hospitals), and Region: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire global 3D Bioprinting market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global 3D Bioprinting market in every aspect of the classification from perspectives of Component, Material, Technology, Application, End User, and Region.
Based on Component, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• 3D Bioprinters
• Bioinks
o Natural Bioinks
o Hybrid Bioinks
o Synthetic Bioinks
Based on Material, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Living Cells
• Hydrogels
• Extracellular Matrices
• Other Material Types
By Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Inkjet 3D Bioprinting
• Laser-assisted Bioprinting
• Magnetic 3D Bioprinting
• Microextrusion Bioprinting
• Other Technologies
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Research Application
o Drug Research
o Regenerative Medicine
o 3D Cell Culture
• Clinical Application
o Skin
o Bone and Cartilage
o Blood Vessels
o Other Clinical Applications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Research Organization & Academic Institutes
• Biopharmaceutical Companies
• Hospitals
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE，Saudi Arabia， South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Component, Material and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
3D Bio-printing Solutions
3D Systems Inc.
3DBio Therapeutics
Advanced Solutions Life Sciences LLC (ASI)
Aspect Biosystems Ltd.
Bico Group AB
Brinter
Cellink AB
CollPlant Biotechnologies Ltd.
Cyfuse Biomedical K. K.
Digilab Inc.
EnvisionTEC GmbH (Desktop Metal Inc.)
Foldink Life Science Technologies
GeSiM - Gesellschaft für Silizium-Mikrosysteme mbH
Inventia Life Science Pty Ltd.
Nano3D Biosciences Inc.
Organovo Holdings Inc
Pandorum Technologies Pvt. Ltd.
Poietis
Precise Bio
Prellis Biologics
Regemat 3D S.L.
RegenHU SA
Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.)
ROKIT Healthcare, INC.
Stratasys Ltd.
TeVido BioDevices, Inc.
Vivax Bio, LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 27
2.2 Major Growth Drivers 29
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter's Fiver Forces Analysis 42
3 Segmentation of Global Market by Component 46
3.1 Market Overview by Component 46
3.2 3D Bioprinters 48
3.3 Bioinks 51
4 Segmentation of Global Market by Material 53
4.1 Market Overview by Material 53
4.2 Living Cells 55
4.3 Hydrogels 56
4.4 Extracellular Matrices 57
4.5 Other Material Types 58
5 Segmentation of Global Market by Technology 59
5.1 Market Overview by Technology 59
5.2 Inkjet 3D Bioprinting 61
5.3 Laser-assisted Bioprinting 62
5.4 Magnetic 3D Bioprinting 63
5.5 Microextrusion Bioprinting 64
5.6 Other Technologies 65
6 Segmentation of Global Market by Application 66
6.1 Market Overview by Application 66
6.2 Research Application 68
6.2.1 Drug Research 69
6.2.2 Regenerative Medicine 70
6.2.3 3D Cell Culture 71
6.3 Clinical Application 72
6.3.1 Skin 73
6.3.2 Bone and Cartilage 74
6.3.3 Blood Vessels 75
6.3.4 Other Clinical Applications 76
7 Segmentation of Global Market by End User 77
7.1 Market Overview by End User 77
7.2 Research Organization & Academic Institutes 79
7.3 Biopharmaceutical Companies 80
7.4 Hospitals 81
7.5 Other End Users 82
8 Segmentation of Global Market by Region 83
8.1 Geographic Market Overview 2021-2031 83
8.2 North America Market 2021-2031 by Country 87
8.2.1 Overview of North America Market 87
8.2.2 U.S. 91
8.2.3 Canada 94
8.2.4 Mexico 96
8.3 European Market 2021-2031 by Country 98
8.3.1 Overview of European Market 98
8.3.2 Germany 102
8.3.3 U.K. 104
8.3.4 France 106
8.3.5 Spain 108
8.3.6 Italy 110
8.3.7 Netherlands 112
8.3.8 Rest of European Market 114
8.4 Asia-Pacific Market 2021-2031 by Country 116
8.4.1 Overview of Asia-Pacific Market 116
8.4.2 Japan 120
8.4.3 China 123
8.4.4 Australia 125
8.4.5 India 127
8.4.6 South Korea 129
8.4.7 Rest of APAC Region 131
8.5 South America Market 2021-2031 by Country 133
8.5.1 Argentina 136
8.5.2 Brazil 138
8.5.3 Chile 140
8.5.4 Rest of South America Market 142
8.6 MEA Market 2021-2031 by Country 143
8.6.1 UAE 146
8.6.2 Saudi Arabia 148
8.6.3 South Africa 150
8.6.4 Other National Markets 152
9 Competitive Landscape 153
9.1 Overview of Key Vendors 153
9.2 New Product Launch, Partnership, Investment, and M&A 156
9.3 Company Profiles 157
3D Bio-printing Solutions 157
3D Systems Inc. 159
3DBio Therapeutics 160
Advanced Solutions Life Sciences LLC (ASI) 161
Aspect Biosystems Ltd. 162
Bico Group AB 163
Brinter 164
Cellink AB 165
CollPlant Biotechnologies Ltd. 166
Cyfuse Biomedical K. K. 167
Digilab Inc. 168
EnvisionTEC GmbH (Desktop Metal Inc.) 169
Foldink Life Science Technologies 170
GeSiM - Gesellschaft für Silizium-Mikrosysteme mbH 171
Inventia Life Science Pty Ltd. 172
Nano3D Biosciences Inc. 173
Organovo Holdings Inc 174
Pandorum Technologies Pvt. Ltd. 175
Poietis 176
Precise Bio 177
Prellis Biologics 178
Regemat 3D S.L. 179
RegenHU SA 180
Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.) 181
ROKIT Healthcare, INC. 182
Stratasys Ltd. 183
TeVido BioDevices, Inc. 184
Vivax Bio, LLC 185
RELATED REPORTS 186
The 3D Bioprinting Technologies Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The 3D Bioprinting For Regenerative Medicine Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The 3D Bioprinting Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacture...
Overview of the Global 3D Bioprinting Technology Market:
The report discusses everything a marketer requires before investing in the global 3D Bioprinting Technology Market during the forecast period 2023-2030. It p...
Overview of the Global 3D Cell Culture and 3D Bioprinting Market:
The report discusses everything a marketer requires before investing in the global 3D Cell Culture and 3D Bioprinting Market during the forecast peri...
The global 3D Bioprinting market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field...
The global 3D Bioprinting and Bioink market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in...
Overview of the Global Bioprinting Services Market:
The report discusses everything a marketer requires before investing in the global Bioprinting Services Market during the forecast period 2023-2030. It provides de...
Overview of the Global 3D Bioprinting for Life Science R and D market:
The report discusses everything a marketer requires before investing in the global 3D Bioprinting for Life Science R and D market during the for...
Overview of the Global Multi-Material 3D Bioprinting Market:
The report discusses everything a marketer requires before investing in the global Multi-Material 3D Bioprinting Market during the forecast period 2023-20...